Theres a lot of demand for these medications, said Juliette Cubanski, deputy director of KFFs Medicare policy program, referring to how private Medicare plans seek to attract seniors
adults who are overweight and obese may be suitable for tirzepatide, marketed as a weight-loss medication under the brand name Zepbound
PubMed CrossRef Perlis LT, Lamberti JS, Miedlich SU
Glucagon-like peptide-1 (GLP-1) receptor agonists aka the -tides, GLP analogs, incretin mimetics *The FDA has approved the use of -glutides to reduce the risk of major cardiovascular events (myocardial infarction, stroke, cardiovascular death) in adults with type 2 diabetes and established cardiovascular disease or multiple cardiovascular risk factors
But here's the thing I need you to hear: the brain doesn't have separate volume knobs for food cravings and life cravings